Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
- PMID: 20141642
- PMCID: PMC2825204
- DOI: 10.1186/1471-2261-10-7
Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
Abstract
Background: Atrial fibrillation (AF) occurs in about 27% to 40% of post cardiac surgery patients. AF following coronary artery bypass graft surgery (CABG) is associated with a two-fold increase in morbidity and mortality. Various demographic risk factors and medications have been studied to predict the occurrence of this arrhythmia. The role of angiotensin related medications on the occurrence of AF in CABG patients is not determined.
Methods: Retrospective clinical and statistical analysis was made of all the patients who had undergone CABG surgery at Lehigh Valley Hospital during the years 2005 and 2006. Patients with chronic AF and those undergoing valvular surgery with CABG were excluded. Statistic analysis included chi-square test for categorical and student t-test for continuous variables.
Results: 757 patients (560 males and 197 females) were studied. AF occurred in 19% of the patients. Age (70.5 vs. 65.1, p < 0.005. OR per year of age: 1.02, 95%CI: 1.018-1.023) and presence of hypertension (OR: 1.92, 95%CI: 1.086-3.140, p = 0.025) were significantly associated with occurrence of AF. Neither ARBs (OR: 0.78, 95%CI: 0.431-1.410, p = 0.41) nor ACE inhibitors (OR: 1.01, 95%CI: 0.753-1.608, p = 0.63) reduced the occurrence of post operative AF. Patients with post operative AF had a significantly longer hospital stay (9.5 +/- 5.4 days vs. 6.9 +/- 4.3 days, p = 0.001).
Conclusions: Advanced age and presence of hypertension were independent predictors of post-CABG AF. Patients with post operative AF had significantly longer hospital stay. Neither ARBs nor ACE inhibitors were associated with reduction of post-surgical AF. Further studies are needed to better delineate the role of angiotensin related medications on reduction of post-surgical AF.
Similar articles
-
Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.Am J Cardiovasc Drugs. 2011 Aug 1;11(4):277-84. doi: 10.2165/11587160-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21623642 Clinical Trial.
-
Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.Ann Pharmacother. 2012 Sep;46(9):1239-44. doi: 10.1345/aph.1R128. Epub 2012 Sep 4. Ann Pharmacother. 2012. PMID: 22947592 Review.
-
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.Ann Pharmacother. 2007 Mar;41(3):433-7. doi: 10.1345/aph.1H583. Epub 2007 Mar 6. Ann Pharmacother. 2007. PMID: 17341525
-
Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation.Int J Cardiol. 2008 Jul 21;127(3):362-7. doi: 10.1016/j.ijcard.2007.05.012. Epub 2007 Aug 10. Int J Cardiol. 2008. PMID: 17692951 Clinical Trial.
-
The role of the renin angiotensin system blocking in the management of atrial fibrillation.Acta Cardiol. 2008 Aug;63(4):457-65. doi: 10.2143/AC.63.4.2033044. Acta Cardiol. 2008. PMID: 18795583 Review.
Cited by
-
Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery.Thorac Cardiovasc Surg. 2019 Mar;67(2):107-116. doi: 10.1055/s-0038-1667065. Epub 2018 Aug 2. Thorac Cardiovasc Surg. 2019. PMID: 30071562 Free PMC article.
-
Atrial fibrillation.J Biomed Res. 2014 Jan;28(1):1-17. doi: 10.7555/JBR.28.20130191. Epub 2013 Dec 28. J Biomed Res. 2014. PMID: 24474959 Free PMC article. Review.
-
Post-operative atrial fibrillation: a maze of mechanisms.Europace. 2012 Feb;14(2):159-74. doi: 10.1093/europace/eur208. Epub 2011 Aug 6. Europace. 2012. PMID: 21821851 Free PMC article. Review.
-
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).Europace. 2017 Feb 1;19(2):190-225. doi: 10.1093/europace/euw242. Europace. 2017. PMID: 28175283 Free PMC article. Review. No abstract available.
-
Primary Prevention of Atrial Fibrillation where are we in 2012?J Atr Fibrillation. 2012 Aug 20;5(2):608. doi: 10.4022/jafib.608. eCollection 2012 Aug-Sep. J Atr Fibrillation. 2012. PMID: 28496763 Free PMC article. Review.
References
-
- Ahlsson A, Bodin L, Fengsrud E, Englund A. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality. Scand Cardiovasc J. 2009;12:1–7. - PubMed
-
- Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–52. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous